David Sholehvar Neogenomics Inc (NEO) insider trading activity
David Sholehvar is President, Clinical Services of NEOGENOMICS INC. Currently has a direct ownership of 43,216 shares of NEO, which is worth approximately $587,305. The most recent transaction as insider was on Aug 01, 2022, when has been sold 12,352 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
43.2K
0%
3M change
0%
12M change
Total Value Held
$587,305
David Sholehvar Transaction History
Also insider at
DS
David Sholehvar
President, Clinical Services
Fort Myers, FL